Summary
Michael Dodds is a pharmacometrics leader with over 20 years of experience applying quantitative models of biology and pharmacology to optimize drug development decisions across preclinical and clinical programs. Currently a Vice President at Lumen Bioscience and an Executive Director at Certara, he has guided dose selection, trial design, and regulatory interactions for biologics and small molecules at Amgen, ZymoGenetics and beyond. He combines deep technical fluency in population modeling tools (NONMEM, PDx-Pop), programming (MATLAB, C++, R/SAS) and model-based decision frameworks with a PhD in Bioengineering to translate complex data into business-impacting choices. Known for bridging rigorous academic methods and practical implementation, he has contributed to both methodological research and hands-on integration of LIMS/databases with analysis pipelines. Based in Seattle, he brings a rare mix of domain expertise, regulatory experience, and systems-level thinking that de-risks development programs and accelerates go/no-go decisions.
11 years of coding experience
19 years of employment as a software developer
Ph.D. Bioengineering, Ph.D. Bioengineering at University of Washington
B.S. Chemical Engineering, B.S. Chemical Engineering at North Carolina State University
G.E.D., G.E.D. at North Carolina School of Science and Mathematics
M.S. Chemical Engineering, M.S. Chemical Engineering at Montana State University-Bozeman